Publication & Citation Trends
Publications
34 total
Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study
Cited by 1
Semantic Scholar
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.
Cited by 29
Semantic Scholar
Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial OA
Cited by 46
Semantic Scholar
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer OA
Cited by 44
Semantic Scholar
POS-507 OCCUPATIONAL HEAT EXPOSURE AS A RISK FACTOR FOR END-STAGE KIDNEY DISEASE OA
Cited by 0
Semantic Scholar
1157. Clinical Safety, Efficacy, and Pharmacokinetics of Fosmanogepix, a Novel First-in-class Antifungal, in Patients with Renal Insufficiency: Subset Analysis from a Phase 2 Candidemia Trial OA
Cited by 7
Semantic Scholar
147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial OA
Cited by 11
Semantic Scholar
Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017 OA
Cited by 55
Semantic Scholar
Research Topics
Antifungal resistance and susceptibility
(15)
Fungal Infections and Studies
(11)
Nail Diseases and Treatments
(7)
Neutropenia and Cancer Infections
(7)
Herpesvirus Infections and Treatments
(4)
Affiliations
Tunis University
Université Libre de Bruxelles
Institut Jules Bordet
Faculté de médecine de Tunis